Pharmaceuticals company Ipca Laboratories announced Q1FY25 results: Standalone Net total Income up 3% at Rs 1,581.25 crore. Consolidated Net total Income up 30% at Rs 2,113.24 crore. Indian formulations income up 12% at Rs 873.37 crore. Exports Income down 4% at Rs 590.86 crore. Standalone EBITDA margin (before forex (gain)/loss, other income and exceptional items) @ 22.25% in Q1FY25 as against @19.13% in Q1FY24. Consolidated EBITDA margin (before forex (gain)/loss, other income and exceptional items) @ 18.52 % in Q1FY25 as against @ 18.57 % in Q1FY24. Standalone Net Profit at Rs 204.13 crore (after exceptional items) up 23%. Consolidated Net Profit at Rs 192.24 crore (after exceptional items) up 18 %. Result PDF